Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APS

Liu, HJ; Li, C; Shi, H; Guo, YX; Tang, YD; Chen, C; Zhao, Z; Hoy, CK; Yalavarthi, S; Figueroa-Parra, G; Duarte-Garcia, A; Zuo, Y; Li, ZG; Knight, JS; Guo, JP

Guo, JP (通讯作者),Peking Univ Peoples Hosp, Dept Rheumatol & Immunol, 11 South Xizhimen St, Beijing 100044, Peoples R China.

RHEUMATOLOGY, 2022; 61 (12): 4962

Abstract

Objective Leucocyte immunoglobulin-like receptor A3 (LILRA3) belongs to a family of leucocyte receptors. Our previous study reported LILRA3 transcript......

Full Text Link